Senior Director Translational Science Lead

At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where 'Health for all Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining ‘impossible’. There are so many reasons to join us. If you’re hungry to build a varied and meaningful career in a community of brilliant and diverse minds to make a real difference, there’s only one choice.

Senior Director Translational Science Lead 

The Senior Director, Translational Science Lead (TSL) is a key figure for advancing the oncology portfolio. The TSL creates significant impact through the successful progression of global development programs and pipeline expansion, from early target assessment through life cycle management. The TSL sets the vision and strategic direction of assigned programs and is responsible for state-of-the-art precision medicine, including all aspects of patient segmentation and proof of mechanism for product differentiation from pre-D1 through registration including companion diagnostics strategies as appropriate.

In addition, every TSL is accountable for significantly shaping technical excellence within TSO by driving core projects and innovation under a peer-reviewed setting, as well as pushing the boundaries of diagnostic in accordance with TSO vision in close collaboration with internal and external partners.

YOUR TASKS AND RESPONSBILITIES

The primary responsibilities of the Translational Science Lead are to:

• Responsible for the integrated translational sciences strategy delivered to the IPT, strategically directing the global, integrated, translational sciences activities by providing relevant expertise and leadership in precision medicine both professionally and scientifically. As such, the TSL ensures consistent high quality and speed of Translational Science deliverables to drive sustained value creation for patients and the business and ensures an “end-to-end” translational vision and strategy for the respective asset(s). The TSL pushes the boundaries of seamless translation to provide the right data at the right time, accelerating and improving decision making, while continuously implementing a patient-centric perspective;
• Responsible for developing translational strategies from pre-clinical stages, bringing new agents to the clinic starting with Target validation/pre-D1. Ensures critical input and continued support of preclinical projects with TS expertise including designing companion diagnostics meeting various HA requirements, taking local requirements (e.g., CHGRAO) in account;
• Ensure an innovative, cutting-edge global translational science portfolio (from early to late development/life cycle management) by developing a patient-centric vision, setting up and steering strategic partnerships with technology providers and key opinion leaders. May be a member of joint coordination committees/steering committees/advisory boards to maximize value for the Bayer oncology portfolio;
• Accountable for the timely delivery of TS milestones, mitigates roadblocks and is empowered to take decisions to effectively execute on the translational strategy;
• Guides and extensively contributes to the preclinical evaluation and validation of new oncology assets in line with the overarching RED ONC strategy focusing on value, differentiation, and unmet medical need (e.g., through interacting with BD&L, LEAPS, Collaboration to Cure Hubs, CoLab incubator);
• Independently leads motivated and engaged teams while role modelling and fostering effective team behavior to achieve development program goals;
• Takes accountability to further develop the TSO organization beyond assigned programs to strengthen team setup and resilience.

WHO YOU ARE

Your success will be driven by your demonstration of our life values, more specifically related to this position, Bayer seeks an incumbent who possesses the following:

Required Qualifications:

• MD and/or PhD in Biochemistry, molecular Biology, Genetics or equivalent ;
• Scientific excellence: Demonstrated by a track record of relevant basic and/or translational research documented in peer reviewed publications;
• Outstanding drug development expertise:
  • Demonstrated ability to integrate innovation to advance Precision Medicine in Oncology
  • Demonstrated Network of KOLs and relevant external companies
  • Relevant global health authority interactions for both drug and device divisions, current knowledge of regulatory review and responses
  • Understanding of scientific, commercial, ethical and legal aspects of the field; 
• Sets the right priorities, seizes strategic opportunities, and adheres to high standards;
• Shows excellent communication and leadership skills, coupled with strategic thinking and foresight as well as outstanding business and external trends insights;
• Focuses on outcomes – independently defines and proactively delivers on highest and aspirational pipeline, team, talent and organizational impact outcomes;
• Acts, learns fast and evolves: works in 90-days cycles, applies learnings very fast and continually develops;
• Co-creates for customers: remains close to the customer - envisions, proactively conceptualizes and co-creates solutions for their needs;
• High energy with focus and vision; self-motivated with a high sense of ownership, urgency, proactive and solution-oriented, flexible entrepreneurial and open-minded approach to new and creative ideas.
• Excellent interpersonal and communication skills.

Preferred qualifications:

• 8-10 years of industry experience in the field of biomarkers/precision medicine with proven track record of successful leadership in this field.